TITLE

Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs

AUTHOR(S)
Zebisch, Armin; Hatzl, Stefan; Pichler, Martin; Wölfler, Albert; Sill, Heinz
PUB. DATE
December 2016
SOURCE
International Journal of Molecular Sciences;Dec2016, Vol. 17 Issue 12, p2080
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Acute myeloid leukemia (AML) is caused by malignant transformation of hematopoietic stem or progenitor cells and displays the most frequent acute leukemia in adults. Although some patients can be cured with high dose chemotherapy and allogeneic hematopoietic stem cell transplantation, the majority still succumbs to chemoresistant disease. Micro-RNAs (miRNAs) and long non-coding RNAs (lncRNAs) are non-coding RNA fragments and act as key players in the regulation of both physiologic and pathologic gene expression profiles. Aberrant expression of various non-coding RNAs proved to be of seminal importance in the pathogenesis of AML, as well in the development of resistance to chemotherapy. In this review, we discuss the role of miRNAs and lncRNAs with respect to sensitivity and resistance to treatment regimens currently used in AML and provide an outlook on potential therapeutic targets emerging thereof.
ACCESSION #
120516904

 

Related Articles

  • Activation of Evi1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells. Kustikova, O S; Schwarzer, A; Stahlhut, M; Brugman, M H; Neumann, T; Yang, M; Li, Z; Schambach, A; Heinz, N; Gerdes, S; Roeder, I; Ha, T C; Steinemann, D; Schlegelberger, B; Baum, C // Leukemia (08876924);May2013, Vol. 27 Issue 5, p1127 

    The transcription factor Evi1 has an outstanding role in the formation and transformation of hematopoietic cells. Its activation by chromosomal rearrangement induces a myelodysplastic syndrome with progression to acute myeloid leukemia of poor prognosis. Similarly, retroviral insertion-mediated...

  • Expression of the lymphoid enhancer factor 1 is required for normal hematopoietic stem and progenitor cell function. Edmaier, K E; Stahnke, K; Vegi, N; Mulaw, M; Ihme, S; Scheffold, A; Rudolph, K L; Buske, C // Leukemia (08876924);Jan2014, Vol. 28 Issue 1, p227 

    The article presents a study which showed that lymphoid enhancer factor-1 (LEF-1) overexpression induces acute myeloid leukemia (AML) in mice, which is propagated by leukemic stem cells with lymphoid characteristics. It outlines a hypothesis that suppression of physiological Lef-1 expression...

  • Epigenomic analysis of the HOX gene loci reveals mechanisms that may control canonical expression patterns in AML and normal hematopoietic cells. Spencer, D H; Young, M A; Lamprecht, T L; Helton, N M; Fulton, R; O'Laughlin, M; Fronick, C; Magrini, V; Demeter, R T; Miller, C A; Klco, J M; Wilson, R K; Ley, T J // Leukemia (08876924);Jun2015, Vol. 29 Issue 6, p1279 

    HOX genes are highly expressed in many acute myeloid leukemia (AML) samples, but the patterns of expression and associated regulatory mechanisms are not clearly understood. We analyzed RNA sequencing data from 179 primary AML samples and normal hematopoietic cells to understand the range of...

  • Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells. Dolatshad, H; Pellagatti, A; Fernandez-Mercado, M; Yip, B H; Malcovati, L; Attwood, M; Przychodzen, B; Sahgal, N; Kanapin, A A; Lockstone, H; Scifo, L; Vandenberghe, P; Papaemmanuil, E; Smith, C W J; Campbell, P J; Ogawa, S; Maciejewski, J P; Cazzola, M; Savage, K I; Boultwood, J // Leukemia (08876924);May2015, Vol. 29 Issue 5, p1092 

    The splicing factor SF3B1 is the most commonly mutated gene in the myelodysplastic syndrome (MDS), particularly in patients with refractory anemia with ring sideroblasts (RARS). We investigated the functional effects of SF3B1 disruption in myeloid cell lines: SF3B1 knockdown resulted in growth...

  • Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia. Qiu, J J; Zeisig, B B; Li, S; Liu, W; Chu, H; Song, Y; Giordano, A; Schwaller, J; Gronemeyer, H; Dong, S; So, C W E // Leukemia (08876924);May2015, Vol. 29 Issue 5, p1153 

    While the nucleoporin 98-retinoic acid receptor gamma (NUP98-RARG) is the first RARG fusion protein found in acute leukemia, its roles and the molecular basis in oncogenic transformation are currently unknown. Here, we showed that homodimeric NUP98-RARG not only acquired unique nuclear...

  • Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice. Basova, P; Pospisil, V; Savvulidi, F; Burda, P; Vargova, K; Stanek, L; Dluhosova, M; Kuzmova, E; Jonasova, A; Steidl, U; Laslo, P; Stopka, T // Oncogene;9/25/2014, Vol. 33 Issue 39, p4735 

    PU.1 downregulation within hematopoietic stem and progenitor cells (HSPCs) is the primary mechanism for the development of acute myeloid leukemia (AML) in mice with homozygous deletion of the upstream regulatory element (URE) of PU.1 gene. p53 is a well-known tumor suppressor that is often...

  • Quantifying Adhesion Mechanisms and Dynamics of Human Hematopoietic Stem and Progenitor Cells. Burk, Alexandra S.; Monzel, Cornelia; Yoshikawa, Hiroshi Y.; Wuchter, Patrick; Saffrich, Rainer; Eckstein, Volker; Tanaka, Motomu; Ho, Anthony D. // Scientific Reports;3/27/2015, p9370 

    Using planar lipid membranes with precisely defined concentrations of specific ligands, we have determined the binding strength between human hematopoietic stem cells (HSC) and the bone marrow niche. The relative significance of HSC adhesion to the surrogate niche models via SDF1α-CXCR4 or...

  • Loss of Dnmt3a and endogenous KrasG12D/+ cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis. Chang, Y-I; You, X; Kong, G; Ranheim, E A; Wang, J; Du, J; Liu, Y; Zhou, Y; Ryu, M-J; Zhang, J // Leukemia (08876924);Sep2015, Vol. 29 Issue 9, p1847 

    Oncogenic NRAS and KRAS mutations are prevalent in human juvenile and chronic myelomonocytic leukemia (JMML/CMML). However, additional genetic mutations cooperating with oncogenic RAS in JMML/ CMML progression and/or their transformation to acute myeloid leukemia (AML) remain largely unknown....

  • Leukemia-related chromosomal loss detected in hematopoietic progenitor cells of benzene-exposed workers. Zhang, L; Lan, Q; Ji, Z; Li, G; Shen, M; Vermeulen, R; Guo, W; Hubbard, A E; McHale, C M; Rappaport, S M; Hayes, R B; Linet, M S; Yin, S; Smith, M T; Rothman, N // Leukemia (08876924);Dec2012, Vol. 26 Issue 12, p2494 

    Benzene exposure causes acute myeloid leukemia and hematotoxicity, shown as suppression of mature blood and myeloid progenitor cell numbers. As the leukemia-related aneuploidies monosomy 7 and trisomy 8 previously had been detected in the mature peripheral blood cells of exposed workers, we...

  • MicroRNA-223 Regulates Granulopoiesis but Is Not Required for HSC Maintenance in Mice. Trissal, Maria C.; DeMoya, Ricardo A.; Schmidt, Amy P.; Link, Daniel C. // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    MIR233 is genetically or epigenetically silenced in a subset of acute myeloid leukemia (AML). MIR223 is normally expressed throughout myeloid differentiation and highly expressed in hematopoietic stem cells (HSCs). However, the contribution of MIR223 loss to leukemic transformation and HSC...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics